The award supports development of a portable test system using the firm's protein nucleic acid probes and semiconductor sensor tech.
The platform analyzes infrared spectroscopy data from a small sample of blood with proprietary algorithms to detect cancer early.
The new funding will help the cluster build on initial milestones and to prepare for clinical applications, particularly in cancer.
Life Line aims to offer Lucent's blood-based testing through its mobile delivery model at urban and rural community health screening events.
Natera expects additional reimbursement coverage for its oncology tests in 2026 that may drive increases in average selling prices and volumes, company executives said on Thursday. Separately this ...
BioAffinity Technologies said on Wednesday that it will run a study of its CyPath Lung test for early lung cancer detection in collaboration with Brooke Army Medical Center (BAMC). CyPath Lung ...
The Phase II study will evaluate CytoDyn's leronlimab in combination with TAS-102 and bevacizumab in patients with relapsed or refractory metastatic colorectal cancer. Hepion Further Cements Shift ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results